EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Does Piperacillin-Tazobactam Increase Mortality Risk Compared With Cefepime? Collider Bias and the Importance of Assumptions in Instrumental Variable Analyses

Fergus Hamilton iD, Todd C Lee iD, George Davey Smith iD, Fernando P Hartwig iD, Guillaume Butler-Laporte iD

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciaf317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Fergus Hamilton und 4 weiteren Autor:innen. Beteiligte Einrichtung: MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom. Hauptthemen laut MEDLINE: Piperacillin, Tazobactam Drug Combination, Anti-Bacterial Agents, Sepsis, Cephalosporins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Instrumental variable (IV) analysis is a statistical method allowing causal inference under certain assumptions. A recent high-profile IV analysis suggested cefepime was superior to piperacillin-tazobactam in treating sepsis. This study used a worldwide piperacillin-tazobactam shortage as an IV to infer mortality effects. However, this result starkly contrasts with the well-powered ACORN trial, which showed no effect. We discuss important limitations of the IV study, potentially explaining this discrepancy.

Methods

We used causal diagrams and the potential outcomes framework to describe potential biases. We identified 2 sources: (1) statistical adjustment for metronidazole treatment, leading to collider bias, and (2) operationalization of the treatment variable (exposure coarsening). We performed simulations demonstrating collider bias can explain the results. Finally, we used summary data from the original paper to obtain alternative causal estimates robust to these biases.

Results

Adjusting for metronidazole, a choice influenced by both the IV (via initial antibiotic) and underlying factors such as disease severity, induces collider bias. Analyses not adjusting for metronidazole show no strong evidence for a mortality difference. However, bias risk from exposure coarsening remains even without adjustment. Re-analyzing summary data provides no compelling evidence for a benefit of cefepime over piperacillin-tazobactam.

Conclusions

The recent IV analysis does not support a mortality benefit for cefepime; results appear dependent on incorrect analytical choices introducing bias. Clinicians should be aware of IV analysis complexities and assumptions when making causal inferences from observational data, especially when results contradict high-quality trials and antibiotic choice is the exposure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Piperacillin, Tazobactam Drug CombinationAnti-Bacterial AgentsSepsisCephalosporinsPenicillanic AcidHumansCefepimeBiasPiperacillinMetronidazole

Stichwörter der Autor:innen

cefepimecollider biasinstrumental variablepiperacillin-tazobactamsepsis

Substanzen

CefepimePiperacillin, Tazobactam Drug CombinationAnti-Bacterial AgentsCephalosporinsPiperacillinPenicillanic AcidMetronidazole

Autor:innen und Institutionen

  • MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.
  • Infection Science, North Bristol NHS Trust, Bristol, United Kingdom.
  • Division of Infectious Diseases, Department of Medicine, McGill University, Montreal, Canada.
  • Federal University of Pelotas, Pelotas, Brazil.
  • Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Canada.

ORCID-Profile: Fergus Hamilton, Todd C Lee, George Davey Smith, Fernando P Hartwig, Guillaume Butler-Laporte

Förderung

  • National Institute for Health and Care Research

Zitieren

APA

Hamilton, F., Lee, T. C., Davey Smith, G., Hartwig, F. P., & Butler-Laporte, G. (2026). Does Piperacillin-Tazobactam Increase Mortality Risk Compared With Cefepime? Collider Bias and the Importance of Assumptions in Instrumental Variable Analyses. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf317

Vancouver

Hamilton F, Lee TC, Davey Smith G, Hartwig FP, Butler-Laporte G. Does Piperacillin-Tazobactam Increase Mortality Risk Compared With Cefepime? Collider Bias and the Importance of Assumptions in Instrumental Variable Analyses. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciaf317

BibTeX
@article{Hamilton2026,
  author = {Hamilton, Fergus and Lee, Todd C and Davey Smith, George and Hartwig, Fernando P and Butler-Laporte, Guillaume},
  title = {Does Piperacillin-Tazobactam Increase Mortality Risk Compared With Cefepime? Collider Bias and the Importance of Assumptions in Instrumental Variable Analyses},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciaf317}
}
Kostenlos starten →